EC-NAPROSYN Overview

Active Ingredient(s):
NAPROXEN

Form(s) and Strength(s) Available:

TABLET, DELAYED RELEASE; ORAL: 500MG

Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).

FDA application	Dosage Form	Strength	Marketing Status	Company
NDA #020067	TABLET, DELAYED RELEASE; ORAL	500MG	Prescription	ROCHE PALO

Click on a application number to view drug details

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Health Topics

Resources

Medical Dictionary

Drug Information

Events

«	September 2008
S	M	T	W	T	F	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Who's online

There are currently 0 users and 134 guests online.

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.

last updated on 09-05-2008

Links to Site